Results revealed that CA alleviated inflammatory damage in lipopolysaccharide‐induced L02 cells by inhibiting the TLR4/nuclear factor‐κB pathway, and were promising as potential therapeutics for acute liver failure. This evidence concerns the gene TLR4 and acute liver failure.